
Biotech & Life SciencesConstructionGovernment & CivicDeveloper ToolsFood & AgricultureE-Commerce & MarketplaceEducationPropTechConsumerFintech
Balyasny Asset Management is primarily a multi-strategy asset management firm aiming to generate consistent, uncorrelated returns across various market environments through diverse strategies including equities, fixed income, commodities, and systematic approaches. The firm has also launched its first dedicated venture capital fund, Atlas Growth LP, which focuses on growth-stage enterprise technology startups in sectors such as AI, data infrastructure, healthtech, and cybersecurity, with a strategy to maintain a concentrated portfolio.
They made 3 investments in the last 12 months. Average disclosed round size is $229.4M (across 11 rounds with reported amounts).
Portfolio
11
Fund Size
—
Top Stage
Series C
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series C | $115M | Nov 2025 | |
| SSolve Therapeutics, Inc. | Series D | $120M | Nov 2025 |
| Series C | $238M | May 2025 | |
| Growth | $150M | Mar 2024 | |
| Series D | $230M | Apr 2022 | |
| Series C | $350M | Jul 2021 | |
| Series C | $150M | Jun 2021 | |
| Series F | $225M | May 2021 | |
| Series B | $70M | Aug 2018 | |
| Series F | $550M | Aug 2018 | |
| Growth | $325M | Sep 2015 |
Top Co-Investors
NightDragon2 shared
General Atlantic2 shared
Tiger Global Management2 shared
Norwest Venture Partners2 shared
Battery Ventures2 shared
Camber Creek2 shared
OrbiMed1 shared
ARCH Venture Partners1 shared
Frazier Life Sciences1 shared
S321 shared
Lifeforce Capital1 shared
Cormorant Asset Management1 shared
Axon Partners Group1 shared
Kite, a Gilead Company1 shared
BlackRock1 shared
BAM Elevate1 shared
Insight Partners1 shared
Manhattan Venture Partners1 shared
aCrew1 shared
Last updated: 15 April 2026